You are here: All Products  > Accutar Starts China Phase I Trial of AI-developed Protein Degrader for Breast Cancer

Accutar Starts China Phase I Trial of AI-developed Protein Degrader for Breast Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products